GBIO vs RADX
Comparison between Generation Bio Company (GBIO, Company) and Radiopharm Theranostics Ltd (RADX, Company).
Both GBIO and RADX are from the Healthcare sector.
GBIO vs RADX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
GBIO
$36M
Winner
RADX
$36M
Max Drawdown
GBIO
99.42%
Winner
RADX
79.68%
Sharpe Ratio
GBIO
0.03
Winner
RADX
0.48
5Y Beta
GBIO
N/A
RADX
0.43
Industry
GBIO
Biotechnology
RADX
Biotechnology
P/E Ratio
GBIO
-0.57
RADX
N/A
Forward P/E
GBIO
7.87
RADX
N/A
Debt to Equity
GBIO
0.00%
RADX
N/A
P/S Ratio
GBIO
N/A
RADX
2.22
P/B Ratio
GBIO
N/A
RADX
1.13
GBIO vs RADX - Historical Returns
Returns include dividend reinvestment.
1M
GBIO
-2.55%
Winner
RADX
+2.64%
3M
Winner
GBIO
-2.38%
RADX
-12.68%
6M
Winner
GBIO
+30.24%
RADX
+0.23%
1Y
GBIO
-23.71%
Winner
RADX
-19.89%
5Y(CAGR)
GBIO
-56.15%
RADX
N/A
Max(CAGR)
Winner
GBIO
-49.19%
RADX
-60.80%
GBIO vs RADX - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | GBIO | RADX |
|---|---|---|
| 2026 | -1.93% | -17.25% |
| 2025 | -48.83% | +12.50% |
| 2024 | -43.01% | -74.59% |
| 2023 | -58.85% | N/A |
| 2022 | -49.36% | N/A |
| 2021 | -76.46% | N/A |
| 2020 | +14.82% | N/A |
GBIO vs RADX Drawdown Comparison
The maximum drawdown for GBIO was -99.42%, occurring on Jun 27, 2025. This drawdown has not yet recovered.
The maximum drawdown for RADX was -79.68%, occurring on Jul 7, 2025. This drawdown has not yet recovered.
The current GBIO drawdown is -98.97%. The current RADX drawdown is -77.41%.
| Rank | GBIO | RADX |
|---|---|---|
| #1 | -99.42% Dec 2, 2020 - Jun 27, 2025 | -79.68% Dec 6, 2024 - Jul 7, 2025 |
| #2 | -31.91% Sep 2, 2020 - Nov 13, 2020 | N/A |
| #3 | -26.81% Jun 12, 2020 - Aug 26, 2020 | N/A |
| #4 | -11.32% Nov 17, 2020 - Nov 24, 2020 | N/A |
Correlation
Correlation between GBIO and RADX is 0.07 which considered as a very weak or no correlation - the stocks move independently of each other.
0.07
-101
Select Stocks to Compare
Popular: GBIO vs SPYRADX vs SPY
More Comparisons
Compare with similar stocks